Đekić, D., Bojić, M., Janež, A., Klobučar, S., Hadžimušović, I. G., Ković, T. i Mihalevska, S. (2023). Effectiveness and Safety of iGlarLixi in People with Type 2 Diabetes in Adriatic Region Countries: ENSURE-ADR, a Real-World Study. Diabetes Therapy, 14. (7), 1217-1229. doi: 10.1007/s13300-023-01407-3
Đekić, Danijel, et al. "Effectiveness and Safety of iGlarLixi in People with Type 2 Diabetes in Adriatic Region Countries: ENSURE-ADR, a Real-World Study." Diabetes Therapy, vol. 14, br. 7, 2023, str. 1217-1229. https://doi.org/10.1007/s13300-023-01407-3
Đekić, Danijel, Mirjana Bojić, Andrej Janež, Sanja Klobučar, Iris Grčić Hadžimušović, Tijana Ković i Svetla Mihalevska. "Effectiveness and Safety of iGlarLixi in People with Type 2 Diabetes in Adriatic Region Countries: ENSURE-ADR, a Real-World Study." Diabetes Therapy 14, br. 7 (2023): 1217-1229. https://doi.org/10.1007/s13300-023-01407-3
Đekić, D., et al. (2023) 'Effectiveness and Safety of iGlarLixi in People with Type 2 Diabetes in Adriatic Region Countries: ENSURE-ADR, a Real-World Study', Diabetes Therapy, 14(7), str. 1217-1229. doi: 10.1007/s13300-023-01407-3
Đekić D, Bojić M, Janež A, Klobučar S, Hadžimušović IG, Ković T, i sur.. Effectiveness and Safety of iGlarLixi in People with Type 2 Diabetes in Adriatic Region Countries: ENSURE-ADR, a Real-World Study. Diabetes Therapy [Internet]. 21.05.2023. [pristupljeno 19.08.2024.];14(7):1217-1229. doi: 10.1007/s13300-023-01407-3
D. Đekić, et al., "Effectiveness and Safety of iGlarLixi in People with Type 2 Diabetes in Adriatic Region Countries: ENSURE-ADR, a Real-World Study", Diabetes Therapy, vol. 14, br. 7, str. 1217-1229, Svibanj 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:730778. [Citirano: 19.08.2024.]